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Background
Asthma is probably the most common chronic medical
condition in pregnancy, with a worldwide prevalence
estimated between 8-13%. The present study aims to
identify a possible association between clinical asthma
control by the Global Initiative for Asthma (GINA) with
ACT at the end of the second trimester of pregnancy, a
period considered the highest risk of clinical deteriora-
tion and exacerbations of asthma.
Methods
A retrospective, cross-sectional study of 103 pregnant
women with asthma who were treated during the period
October 2010 to October 2013, the asthma clinic in
pregnancy, Hospital das Clinicas, Federal University of
Pernambuco. The level of asthma control by GINA and
the ACT for pregnant women with asthma was evalu-
ated in the same time period, between the twenty-first
and twenty-seventh week of pregnancy. The association
between the ACT and the level of clinical control by
GINA by Chi-Square test was performed.
Results
A total of 103 pregnant patients with asthma, 79 (76,7%)
with the age range between 18-34 years of age were ana-
lyzed. Analyzing the initial care of these patients, 50
(48,5%) of them were aged < 20 weeks already showing
a high body mass index, overweight in 50 (48,5%) of
them. Of asthmatic pregnant women, 62 (60,2%) used
beta-agonist inhaled short acting during exacerbations
and kept using their inhaled corticosteroids continu-
ously with doses of 400 to 800μg per day. Among the
most frequent comorbidities, stood out hypertension
and gestational diabetes, and among other atopic dis-
eases diagnosed 47 (45,6%) had rhinitis. Mild persistent
asthma was more frequent 51 (49,5%) and the presence
of asthma control showed 8 (11,2%) uncontrolled, 32
(44,4%) partially controlled and 32 (44,4%) controlled. In
the analysis of the association chi-squared test was used
and statistically significant association between the clini-
cal control of asthma by GINA and the ACT in preg-
nancy with p < 0.001.
Conclusions
This study shows that both clinical control by GINA as
ACT can be used in asthmatic pregnant women, espe-
cially at the end of the second trimester, a period of
deterioration and exacerbations of asthma in pregnancy.
We include the importance of the ACT to be a subjec-
tive instrument of easy application, interpretation and
with good reproducibility that does not require spirome-
try to assess the level of asthma control in pregnancy.
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